Ironwood Pharmaceuticals, Inc. (IRWD)
4.235
+0.10
(+2.54%)
USD |
NASDAQ |
Aug 31, 16:00
4.25
+0.02
(+0.35%)
After-Hours: 20:00
Ironwood Pharmaceuticals Cash and Short Term Investments (Quarterly) : 79.13M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 79.13M |
| March 31, 2026 | 220.47M |
| December 31, 2025 | 215.46M |
| September 30, 2025 | 140.41M |
| June 30, 2025 | 92.85M |
| March 31, 2025 | 108.48M |
| December 31, 2024 | 88.56M |
| September 30, 2024 | 88.21M |
| June 30, 2024 | 105.52M |
| March 31, 2024 | 121.54M |
| December 31, 2023 | 92.15M |
| September 30, 2023 | 110.95M |
| June 30, 2023 | 176.11M |
| March 31, 2023 | 741.59M |
| December 31, 2022 | 657.45M |
| September 30, 2022 | 575.44M |
| June 30, 2022 | 505.62M |
| March 31, 2022 | 594.62M |
| December 31, 2021 | 621.38M |
| September 30, 2021 | 575.53M |
| June 30, 2021 | 494.43M |
| March 31, 2021 | 440.20M |
| December 31, 2020 | 364.30M |
| September 30, 2020 | 309.29M |
| June 30, 2020 | 254.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 232.39M |
| December 31, 2019 | 178.27M |
| September 30, 2019 | 146.91M |
| June 30, 2019 | 106.58M |
| March 31, 2019 | 120.30M |
| December 31, 2018 | 174.42M |
| September 30, 2018 | 161.40M |
| June 30, 2018 | 181.25M |
| March 31, 2018 | 194.45M |
| December 31, 2017 | 221.42M |
| September 30, 2017 | 225.42M |
| June 30, 2017 | 272.90M |
| March 31, 2017 | 296.53M |
| December 31, 2016 | 305.22M |
| September 30, 2016 | 319.87M |
| June 30, 2016 | 325.37M |
| March 31, 2016 | 434.95M |
| December 31, 2015 | 439.39M |
| September 30, 2015 | 462.31M |
| June 30, 2015 | 493.32M |
| March 31, 2015 | 215.86M |
| December 31, 2014 | 248.33M |
| September 30, 2014 | 264.96M |
| June 30, 2014 | 301.98M |
| March 31, 2014 | 332.27M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 95.33M |
| AbbVie, Inc. | 6.569B |
| Marker Therapeutics, Inc. | 11.92M |
| Theriva Biologics, Inc. | 11.34M |
| Fortress Biotech, Inc. | 196.58M |